Invesaro

Stocks Health care BAX

NYSE · Health care

Baxter International Inc (BAX)

Baxter International Inc brought in $11.6B of revenue over the twelve months to September 30, 2026, up 5.3% from a year earlier. It posted a net loss of $723M. Operating cash flow minus capital spending left $332M of free cash flow in fiscal 2025. At September 30, 2026 it held $2B in cash against $844M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 29, 2026.

Free, no password. An email when BAX files with the SEC.

Price
$25.82
-2.25% on the day · November 10, 2026
52-week range $15.73 to $30.00
Market cap
$13.3B
Revenue (last 12 months)
$11.6B
+5.3% year on year
Net margin
-6.2%

Key facts about Baxter International Inc

Net worth
Baxter International Inc has a market value (market cap) of $13.3B at the latest share price, and shareholders' equity of $6.5B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $11.2B (+5.7% year on year), with a net loss of $957M. Over the 12 months to September 30, 2026: revenue $11.6B, net loss $723M.
Cash flow
In fiscal 2025 operations brought in $845M of cash; after $513M of capital spending, free cash flow was $332M.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 29, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
Next earnings report
Baxter International Inc's next report is expected around February 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Dividend
Baxter International Inc declared dividends of $0.52 per share in fiscal 2025, a yield of 2.01% at the current price.

What Baxter International Inc does

Baxter International Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NYSE under the ticker BAX.

Revenue and profit by year

Revenue
FY18: $11.1B $11.1B FY18FY19: $11.4B $11.4B FY19FY20: $11.7B $11.7B FY20FY21: $12.1B $12.1B FY21FY22: $10.1B $10.1B FY22FY23: $10.4B $10.4B FY23FY24: $10.6B $10.6B FY24FY25: $11.2B $11.2B FY25
Net income
FY18: $1.5B $1.5B FY18FY19: $1B $1B FY19FY20: $1.1B $1.1B FY20FY21: $1.3B $1.3B FY21FY22: -$2.4B -$2.4B FY22FY23: $2.7B $2.7B FY23FY24: -$649M -$649M FY24FY25: -$957M -$957M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$11.2B-$308M-$957M-$1.87$332M
2024$10.6B$14M-$649M-$1.27$573M
2023$10.4B$707M$2.7B$5.23$1.3B
2022$10.1B-$2.8B-$2.4B-$4.83$834M
2021$12.1B$1.4B$1.3B$2.53$1.5B
2020$11.7B$1.6B$1.1B$2.13$1.2B

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around February 11, 2027.

Estimated from its filing rhythm: 52 weeks after its report of February 12, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where BAX ranks in Health care

Revenue$11.2B
#44 of 751 in Health care · Top 6%
Revenue growth+5.7%
#343 of 532 in Health care · Bottom 36%
Net margin-8.5%
#277 of 544 in Health care · Bottom 49%
Free cash flow margin3.0%
#209 of 490 in Health care · Top 43%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

Baxter International Inc declared $0.52 per share in fiscal 2025. At the current price that is a yield of 2.01%. It paid out $348M in cash dividends.

Fiscal yearPer sharePaid outOf profit
2025$0.52$348Mn/a
2024$1.04$590Mn/a
2023$1.16$586M22%
2022$1.15$573Mn/a
2021$1.09$530M41%
2020$0.96$473M43%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Baxter International Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 29, 2026
    Quarterly report 10-Q · period to September 30, 2026Revenue rose 5% to $3B versus the same quarter last year; diluted EPS $0.57 versus -$0.09.
  2. October 29, 2026
  3. October 27, 2026
  4. August 19, 2026
  5. August 18, 2026
  6. August 4, 2026
  7. August 4, 2026
  8. July 30, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 5.3% to $3B versus the same quarter last year; diluted EPS $0.24 versus $0.18.
  9. July 30, 2026
  10. July 14, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on October 2, 2026. Insider transactions on SEC

What is BAX worth? A DCF from its reported cash flow

Insider trades

What the people running Baxter International Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 3 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
September 2, 2026 Foster JuliePresident, Front Line Care Shares withheld for tax 2,098 $25.70 $53.9K Form 4
September 2, 2026 Hider Andrew P.President and CEO, Director Shares withheld for tax 54,276 $25.70 $1.4M Form 4
September 1, 2026 Teaff JamesPresident, CCS Shares withheld for tax 750 $25.48 $19.1K Form 4
June 2, 2026 Teaff JamesPresident, CCS Shares withheld for tax 321 $18.68 $6K Form 4
June 2, 2026 Wallace Steven P.President, Adv. Surgery Shares withheld for tax 153 $18.68 $2.9K Form 4
June 1, 2026 Zielinski Anita ASVP, Interim CFO, CAO & Cntrlr Received as pay 13,426 - - Form 4
May 5, 2026 Ampofo William A. IIDirector Received as pay 12,836 - - Form 4
May 5, 2026 Craig Jeffrey ADirector Received as pay 12,836 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns BAX

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Pzena Investment Management LLC13G, passive 12.7% 65,347,621 April 21, 2026
Dodge & Cox13G, passive 11.2% 57,396,370 November 13, 2025
Fmr LLC13G, passive with 1 related filers 10.3% 52,972,914 June 5, 2026
BlackRock Portfolio Management LLC13G, passive 8.7% 44,925,341 January 21, 2026
Vanguard Capital Management13G, passive 7.36% 38,033,907 April 29, 2026

Latest filings below 5%: The Vanguard Group 0% (March 26, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 685 managers reported a position.

HolderSharesValueChange on quarter
BlackRock, Inc.81,842,105$1.74B+2,441,441
Pzena Investment Management LLC65,295,393$1.39B+767,570
Dodge & Cox58,386,345$1.24B+1,131,775
Fmr LLC53,913,831$1.15B+7,649,027
Vanguard Capital Management LLC33,754,280$719.6M+247,305
Vanguard Portfolio Management LLC24,057,190$512.9M+63,835
State Street Corp20,600,468$439.4M+620,511
Greenhaven Associates Inc14,285,228$304.6M-22,460
Geode Capital Management, LLC14,123,689$300.6M+360,724
Invesco Ltd.12,361,881$263.6M-759,290
UBS Group AG9,529,309$203.2M+5,209,812
First Pacific Advisors, LP7,618,145$162.4M+917,220
Goldman Sachs Group Inc7,150,462$152.4M+3,280,907
Equity Investment Corp6,886,265$146.8M+516,271
Morgan Stanley6,359,790$135.6M-988,182
Bank of America Corp6,237,950$133M+71,817
State Farm Mutual Automobile Insurance Co6,225,060$132.7M0
Charles Schwab Investment Management Inc5,996,711$127.8M+407,157
Dimensional Fund Advisors LP5,612,144$119.7M-319,647
Northern Trust Corp4,864,004$103.7M+516,686

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

19 insiders reported holding 1,848,024 shares in total, about $47.7M at the last price.

HolderSharesAs of
Hider Andrew P.President and CEO, Director 518,447 September 2, 2026
Grade Joel T.EVP and CFO 271,674 March 6, 2026
Mason Jeanne KEVP, Chief HR Officer 199,853 December 12, 2025
Rosenbloom David S.EVP and General Counsel 138,216 March 6, 2026
Rasul ReazurEVP,Group Pres,Healthcare 125,557 March 6, 2026
Soriano Maria CeciliaGroup Pres., ITT & Pharma. 75,045 March 6, 2026
Shafer David BrentDirector 72,804 May 5, 2026
Wallace Steven P.President, Adv. Surgery 70,128 June 2, 2026
Zielinski Anita ASVP, Interim CFO, CAO & Cntrlr 59,714 June 1, 2026
Wendell Amy McBrideDirector 44,235 May 5, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about BAX

What does Baxter International Inc do?

Baxter International Inc is a company in the Health care sector, listed on NYSE as BAX. Its shares trade on NYSE under the ticker BAX.

What is Baxter International Inc's net worth?

Baxter International Inc has a market value (market cap) of $13.3B at the latest share price, and shareholders' equity of $6.5B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Baxter International Inc profitable?

No. Over the twelve months to September 30, 2026 it reported a net loss of $723M on revenue of $11.6B.

How much revenue does Baxter International Inc make?

Over the twelve months to September 30, 2026 Baxter International Inc reported revenue of $11.6B. That is 5.3% more than a year earlier.

When did Baxter International Inc last report?

Its most recent periodic report is the quarterly report (10-Q) filed on October 29, 2026. It covers the period to September 30, 2026.

When is Baxter International Inc's next earnings report?

Baxter International Inc's next report is expected around February 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Does Baxter International Inc pay a dividend?

Yes. Baxter International Inc declared dividends of $0.52 per share in fiscal 2025, a yield of 2.01% at the current price.

Similar companies

Compare BAX with

Compare BAX with any company

Follow BAX

Get an email when Baxter International Inc files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when BAX files with the SEC.

Where the numbers come from

Financial figures are the values Baxter International Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.